What is SanBio Company Limited?
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. The company is listed on the OTCGREY in USA, operating in the Healthcare sector, with a market capitalisation of 1.28B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.